Trial Profile
Efficacy of labradimil in patients with with carboplatin recurrent glioblastoma multiforme or anaplastic glioma when administered with or without carboplatin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2014
Price :
$35
*
At a glance
- Drugs Labradimil (Primary) ; Carboplatin
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.